课题基金 / 基金详情

The Synergistic Effects of Co-Treatment with Glucagon-Like Peptide-1 and -2 Receptor Agonists on Glucose Metabolism and Intestinal Growth/Function.

The Synergistic Effects of Co-Treatment with Glucagon-Like Peptide-1 and -2 Receptor Agonists on Glucose Metabolism and Intestinal Growth/Function.
胰高血糖素样肽-1 和-2 受体激动剂联合治疗对葡萄糖代谢和肠道生长/功能的协同作用。
批准号:
429063
负责人:
Srikrishnaraj Arjuna
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-12-01 至 2020-12-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"The gastrointestinal tract secretes substances that regulate metabolic homeostasis. Specifically, the L cells, located within the distal portion of the small intestine and the colon, secrete Glucagon-Like Peptide-1 (GLP-1) and -2 (GLP-2) in response to f
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金